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Abstract 
 
  
 Function of the retinoblastoma protein, a master regulator of cell cycle progression, is compromised in 
the majority of cancers. Loss of pRB is known to promote DNA damage during interphase, but its impact 
during mitosis remains unclear. My work demonstrates a novel role for pRB such that its loss promotes high 
levels of DNA damage in mitotic cells. The data suggests that G2/M DNA damage checkpoints in pRB-
deficient cells remain intact, and that damage acquired during interphase does not persist into mitosis. Instead, 
pRB-deficient cells acquire new damage during mitosis. More specifically, in pRB-deficient cells γH2AX DNA 
damage foci are present during normal mitotic timing, exacerbated in response to microtubule poisons that 
prolong mitotic arrest, and accumulate more quickly in pRB-deficient cells than in control cells. Together this 
data suggests that pRB functions to protect against DNA damage following delays in mitotic progression.  
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Chapter I: Retinoblastoma Protein as a Regulator of Genome Stability 
 
Genomic Stability and Cancer 
 
 Genomic instability, characterized by alterations to a cell’s genome, is a hallmark of cancer and has been 
shown to promote tumorigenesis (Meyerson & Pellman, 2011; Thompson & Compton, 2011). Several processes 
of the cell cycle can be disrupted in order to generate genomic instability, including DNA replication, 
chromosome segregation, DNA damage response pathways, and regulation of cell cycle progression (Shen, 
2011). These processes are strictly regulated by cell cycle checkpoints, and it is the loss of function of the 
machinery required for these surveillance systems that onsets malignant transformation.  
 
Overview of Retinoblastoma Protein 
 
 One of the best characterized regulators of the cell cycle is the retinoblastoma tumor suppressor protein 
(pRB). While the canonical role of pRB is as a negative regulator of E2F-dependent transcription and the G1/S 
phase transition, pRB additionally regulates the activity of various downstream targets important in later stages 
of the cell cycle. Several studies have shown the importance of pRB in regulating chromosome cohesion (Ren et 
al., 2002; Manning et al., 2010), chromosome condensation (Ren et al., 2002; Coschi et al., 2010), DNA 
replication (Ren et al., 2002; Srinivasan et al., 2007), DNA damage response (Ren et al., 2002; van Harn et al., 
2010), and chromosome segregation (Ren et al., 2002; Hernando et al., 2004; Manning et al., 2010). It is no 
surprise then that pRB is either loss or functionally inactive most cancers (Horowitz et al., 1990). More 
specifically, the RB gene is often either deleted or the protein itself is functionally inactivated (i.e. constitutively 
hyperphosphorylated) due to either overexpression of RB-inactivating kinases or inactivation of negative 
regulators of these kinases (Damania and Pipas, 2008; Du and Searle, 2009). In some of the earliest studies of 
the RB pathway and cancer, Horowitz et al. showed that the RB gene is inactivated in all retinoblastomas, 
inactivated or alternatively spliced to result in a functional inactive protein in small cell lung cancer, and 
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functionally inactivated in most breast carcinomas and melanomas (Horowitz et al., 1990). Cancer genome 
sequencing has now confirmed that the RB1 gene is mutated in most retinoblastomas, osteosarcomas, and small 
cell lung cancer, and is mutated at lower frequencies in several other cancers (Dyson, 2016). Thus, it is 
important to understand the various roles of pRB with regard to maintaining genome stability to advance upon 
cancer knowledge and therapeutics. 
 
Regulation of Chromatin Structure and Cell Cycle Progression 
 
 There are three major events during a cell cycle - cell growth, DNA replication, and nuclear division 
(Ferrari and Gentili, 2016). Cell growth and DNA replication occur during interphase, which consists of the 
stages G1, S, and G2, while nuclear division occurs during a process known as mitosis (Ferrari and Gentili, 
2016). There are five sub-phases of mitosis - prophase, prometaphase, metaphase, anaphase, and telophase - 
followed by cytokinesis, or the physical separation of the daughter cells (Ferrari and Gentili, 2016). In order for 
a cell to divide, it must undergo an accurate duplication of its DNA during S phase. S phase produces identical 
DNA molecules, referred to as sister chromatids, that become and remain physically connected until anaphase 
by a process known as cohesion (Peters and Nishiyama, 2012). Cohesion is regulated by cohesin, a ring-shaped 
protein complex that loads onto DNA during replication to connect sister chromatids at the centromere and 
along their arms until chromosome segregation (Peters and Nishiyama, 2012). Cohesin is stabilized onto 
chromosomes by the protein soronin, which binds to a subunit of the cohesin complex (Schmitz et al., 2007). 
Cohesin is further regulated by Wapl, which when present in early mitosis competes with sororin for binding 
and releases cohesin from the chromosome arms of DNA (Kueng et al., 2006). Several other proteins are 
responsible for regulating cohesion, including separase, Polo-like kinase (Plk1), cyclin-dependent kinase 1 
(Cdk1), and Aurora B (Losada et al., 2002; Sumara et al., 2002; Kueng et al., 2006; Hegemann et al. 2011). 
Defects in cohesion and its regulation machinery are underlying causes of chromosomal instability (CIN), as the 
inability for sister chromatids to accurately assemble on the mitotic spindle and symmetrically segregate into 
daughter cells results in aneuploidy (Peters and Nishiyama, 2012). Cohesion is also important in accurate DNA 
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repair through homologous recombination (Peters and Nishiyama, 2012). More specifically, cohesin is 
responsible for holding damaged ends of chromosomes together, as well as newly replicated strands behind the 
replication fork together to promote DNA repair surveillance and initiation of homologous recombination 
(Watrin and Peters, 2006). The cohesin complex has also been shown to be recruited to sites of DNA damage, 
and thus is responsible for initiating DNA repair (Strom et al., 2004). As a consequence, defects in cohesion can 
result in defects in the DNA damage repair pathway, and accumulation of DNA damage itself.  
 As the cell progresses into mitosis, the replicated chromatin undergoes a process known as 
condensation. During prophase, a protein complex called condensin II is recruited to the DNA in order to 
supercoil the chromatin for accurate segregation (Uhlmann, 2001; Coschi et al., 2010). Like cohesin, condensin 
II is also regulated by Plk1, Cdk1, and Aurora B (Ferrari and Gentili, 2016). Alongside this process, 
topoisomerase II is responsible for ensuring that the DNA does not get entangled (Uhlmann, 2001). Defects in 
chromosome condensation are another underlying cause of CIN, as they can produce segregation errors such as 
lagging chromosomes, which subsequently result in aneuploidy (Samoshkin et al., 2009).  
 Once the sister chromatids are appropriately attached and condensed, the cell continues with its division. 
During prometaphase and metaphase, Aurora B regulates the attachment of microtubules from the mitotic 
spindle to the kinetochores on the sister chromatids’ centromere region (Cheeseman, 2014). Once attached, 
Aurora A coordinates the action of motor proteins like dynein and CENP-E so that the sister chromatids can 
assembly along the metaphase plate (Kim et al., 2010). Upon progression into anaphase, the anaphase 
promoting complex/cyclosome (APC/C) initiates cohesin removal from the centromere in order to promote 
chromosome segregation (Sivakumar and Gorbsky, 2015). Once the chromatids are positioned at the opposite 
poles of the cell, two new nuclear membranes form and the subsequent daughter cells physically separate (Pines 
and Rieder, 2001). All of the cell cycle is systematically regulated by strict checkpoints - the two most 
prominent being the G2/M checkpoint and the spindle assembly checkpoint (Ferrari and Gentili, 2016). The 
G2/M checkpoint, commonly recognized as the DNA damage checkpoint, is regulated by several key proteins 
including but not limited to ATR, ATM, CHK1, CHK2, Plk1, and Cdk1, while the spindle assembly checkpoint 
is regulated by a different set of proteins with the most prominent being Mad2 (Ferrari and Gentili, 2016). It is 
 4 
often the inactivation or loss of function of these proteins that allow a cell to continue to divide in the presence 
of genomic changes, promoting tumorigenesis.  
 
Function of pRB throughout the Cell Cycle 
 
 Before a cell can even initiate the cohesion process in S phase, however, it must promote the expression 
of all cell cycle proteins previously described – most of which are regulated by the pRB pathway. pRB is best 
known for its negative regulation of the E2F transcription factor family during the G1/S phase transition (Figure 
1). Under normal conditions, pRB restricts a cell from entering S phase until hyperphosphorylation stimulated 
by Cdk4/Cdk6 activity (Weinberg, 1995). During this time, pRB is bound to E2F family members, repressing 
their ability to initiate the transcription of genes whose protein products are necessary for DNA replication 
(Weinberg, 1995). Once a cell has met the criteria to continue onto DNA replication, a growth factor stimulates 
cyclin-Cdk4/Cdk6 activity, subsequently hyperphosphorylating pRB so that it loses its attachment to the E2Fs 
(Weinberg, 1995). Following liberation, E2Fs can then promote the expression of the genes necessary for cell 
cycle progression and mitotic initiation (Weinberg, 1995).  
Figure 1: Schematic of the pRB-E2F Pathway during the G1/S Phase Checkpoint 
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 Although pRB is best known for its function during interphase progression, there are several other roles 
for pRB that are less understood. Studies have shown that pRB-mutant cells have elevated levels of DNA 
damage (Pickering and Kowalik, 2006; van Harn et al., 2010; Bester et al., 2011), but the mechanism as to how  
 
Table 1: Exploring Loss of pRB Cell Cycle Regulation in Promoting DNA Damage 
Possible Promoter of DNA Damage Result of Defect/Misregulation 
Cohesion Defects Cell loses ability to hold damaged ends of 
chromosomes together as well as newly replicated 
DNA strands together, thus disrupting DNA repair by 
limiting homologous recombination (Strom et al., 
2004). Changes in the chromatin landscape can also 
alter the gene expression profile and/or expose 
normally methylated sites for DNA damage.  
Condensation Defects Condensin I is specifically recruited to sites of DNA 
damage, thus defects result in loss of repair initiation 
(Kong et al., 2011). Changes in the chromatin 
landscape can also alter the gene expression profile 
and/or expose normally methylated sites for DNA 
damage. In addition to the role of condensin I in DNA 
damage repair, RB has been shown to interact with 
condensin II (Longsworth et al., 2008), which has also 
been shown to have a role in DNA damage response 
(Floyd et al., 2013). 
Nucleotide Deficiency Failure to support normal DNA replication and repair 
(Bester et al., 2011). 
Misregulated DNA Damage Repair 
Pathway 
Failure to initiate and carry out normal DNA repair 
pathway. RB is phosphorylated in an ATM, Chk1/2 
dependent manner in response to DNA damage, which 
promotes E2F repression and cell cycle arrest (Inoue 
et al., 2007). Thus, inactivation of RB limits DNA 
damage response and promotes accumulation of 
damage.  
Misregulated Spindle Assembly 
Checkpoint 
Misregulated progression of mitosis displays failure to 
initiate and carry out normal DNA repair pathway. 
Loss of correct spindle formation results in lagging 
chromosomes, micronuclei, and chromatin bridges 
(Manning et al., 2010). RB has also been shown to 
bind directly to the APC/C specificity factor Cdh1, 
thus inactivation of RB can limit the cell’s ability to 
induce a cell cycle arrest when such defects arise 
(Binne et al., 2007).  
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pRB loss results in DNA damage is unclear. Furthermore, most of the damage studied due to pRB loss has been 
proposed to be from replication defects, further characterizing its importance in regulating S phase activity but 
not necessarily activity throughout the rest of the cell cycle. Other models suggest that cohesion defects 
(Manning et al., 2010), condensation defects (Coschi et al., 2010), nucleotide deficiency (Bester et al., 2011), 
misregulation of pRB-regulated DNA damage repair factors (Bosco et al., 2005; Genovese et al., 2006; Cook et 
al., 2015), and misregulation of pRB-regulated spindle assembly checkpoint proteins (i.e. Mad2) (Hernando et 
al., 2004) may play a role. Table 1 demonstrates how these changes may cause DNA damage. 
 Several other groups have begun to explore mitotic DNA damage. For example, the Mitchison group 
proposed that a prolonged mitotic arrest has the ability to deplete a cell’s anti-apoptotic factors, which 
subsequently breaks the restraint of caspase activity and the function of caspase activated DNase (CAD) (Orth 
et al., 2012). CAD can then cleave DNA, thereby inducing DNA double stranded breaks (Orth et al., 2012). 
Other groups have explored the DNA damage response pathway itself with regard to mitotic damage, further 
accepting that under normal conditions, the DNA damage response pathway should be inactive during mitosis. 
For example, it has been shown that Plk1 actually functions to inhibit the DNA damage response pathway from 
turning on in response to mitotic damage (Benada et al., 2015), and that inducing the DNA damage response 
pathway during mitosis actually induces segregation errors (Bakhoum et al., 2014). However, no study to date 
considers the possibility of the effect pRB loss can have on mitotic damage.   
 
Objectives & Hypotheses 
 
 This project aims to determine the correlation between pRB loss and DNA damage, specifically during 
mitosis. It is hypothesized that pRB-deficient cells acquire DNA damage during normal mitotic timing. 
Furthermore, similar to control cells undergoing a prolonged mitosis, it is hypothesized that pRB-deficient cells 
acquire caspase-dependent DNA damage that can be prevented by inhibiting caspase activity. Lastly, due to the 
canonical function of pRB in regulating cohesion and the accepted model that increasing cohesion can repair 
DNA damage of interphase pRB-deficient cells, it is further hypothesized that increasing cohesion will also 
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prevent the mitotic DNA damage phenotype. The broader goal of this project is to propose the molecular 
mechanism in which pRB regulates mitotic DNA damage in order to advance cancer therapy research for those 
malignancies in which pRB is lost or inactive.  
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Chapter II: Results 
 
Prolonged Mitosis Induces DNA Damage in Control and pRB-Deficient Cells 
 
 Since previous literature has proposed that pRB-deficient cells experience an increase in mitotic 
chromosome segregation defects (Manning et. al., 2010), I set to determine whether pRB-deficient cells have an 
increase in mitotic DNA damage. In order to accomplish pRB knockdown, RNA interference via siRNA 
transfection was performed. Cells were arrested with the microtubule poison nocodazole for 8 hours to induce a 
mitotic arrest, and then were stained for γH2AX to monitor DNA double stranded break accumulation via 
immunofluorescence imaging. Only mitotic cells were scored, and they were considered to either have no 
damage, low damage, or high damage based on the number of γH2AX foci present (Figure 2). The data first 
suggests that pRB-deficient cells are more susceptible to DNA damage than control cells during normal mitotic 
events (Figure 3). Second, consistent with the literature (Orth et al., 2012), control cells undergoing a prolonged 
mitosis have an increase in DNA damage in comparison to control cells during normal mitotic timing (Figure 
3). pRB-deficient cells undergoing a prolonged mitosis display this same pattern in comparison to control pRB-
deficient cells, but they also have a larger percentage of cells exhibiting high damage in comparison to control 
cells undergoing abnormal mitoses (Figure 3). This suggests a novel role for pRB in the regulation of mitotic 
DNA damage and encourages further mechanistic analysis on how pRB loss promotes mitotic DNA damage.  
 
pRB-Deficient Cells have an Intact G2/M DNA Damage Checkpoint 
 
 Since loss of pRB is accepted to be associated with DNA replication dependent damage, I next 
investigated whether this damage persists into mitosis and could thus account for the difference in levels of 
damage seen between control and pRB-deficient cells during abnormal mitoses. Control and pRB-deficient cells 
were treated with increasing concentrations of the DNA damaging agent Doxorubicin, and the mitotic index of  
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Figure 2: DNA Damage Scoring Parameters. Immunofluorescence imaging showing γH2AX foci categories 
for a cell in normal mitotic timing and a cell treated with the microtubule poison nocodazole. Cells were 
considered to have no damage if no γH2AX foci were present, low damage if 1-4 γH2AX foci were present, or 
high damage if 5 or more γH2AX foci were present. All experiments using siRNA transfection and these 
scoring parameters were performed a minimum of 3 replicates unless otherwise indicated, with a minimum 
number of 50 individual cells per replicate.  
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High Damage (5+ Foci) 0.0168 0.0007 0.0203 0.0273 
 
 
Figure 3: Mitotic Arrest Induces γH2AX DNA Double Stranded Break Response in Control and pRB-
Deficient Cells. Quantification of γH2AX foci scored after immunofluorescence imaging of RPE-1 cells. Cells 
were treated with either siSCR or siRB, and mitotic arrest was induced using the microtubule poison 
nocodazole for 16hr. P-values were calculated by a two-tailed t-test across conditions. Bolded values indicate 
significance. A total of 11 replicates were completed.  
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a minimum of 1000 cells imaged by immunofluorescence was calculated (Figure 4). Untreated conditions were 
the only conditions in which mitotic figures were observed, suggesting that the DNA damage resulting from 
Doxorubicin treatment activated the G2/M DNA damage checkpoint in both control and pRB-deficient cells 
(Figure 4). The data also suggests that pRB-deficient cells are still sensitive to lower concentrations of 
Doxorubicin and thus lower levels of DNA damage similar to control cells. These results indicate that the G2/M 
DNA damage checkpoint in pRB-deficient cells remains intact, suggesting that the damage accumulated in 
pRB-deficient cells during interphase is corrected before entry in mitosis. 
 
pRB-Deficient Cells Accumulate DNA Damage at a Faster Rate than Control Cells during Abnormal Mitoses 
 
 Data thus far has suggested that pRB-deficient cells accumulate DNA damage during mitosis, and 
despite their known characterization for being susceptible to DNA damage acquired during interphase, pRB-
deficient cells have intact DNA damage checkpoints and thus correct any damage before entering mitosis. Thus, 
it is important to determine how DNA damage is acquired in pRB-deficient cells once they enter mitosis.  In 
order to characterize the time course at which pRB-deficient cells acquire mitotic DNA damage, control and 
pRB-deficient cells were treated with nocodazole for various time points and γH2AX foci accumulation was 
scored from immunofluorescence imaging to determine levels of DNA damage. First, the data again shows that 
control cells have a larger percentage of cells with no damage compared to pRB-deficient cells, a difference 
between the 8-hour nocodazole treated time point for both control and pRB-deficient cells, and a statistically 
significant difference in high levels of DNA damage between control and pRB-deficient cells during the 8-hour 
nocodazole treated time point (Figure 5). The data also shows the pRB-deficient cells arrested in mitosis begin 
to accumulate DNA damage as early as the 4-hour mitotic arrest time point, while control cells arrested in 
mitosis do not begin to accumulate statistically significant DNA damage until the 8-hour mitotic arrest time 
point (Figure 5). All together, the data suggests that pRB-deficient cells accumulate more DNA damage than 
control cells during normal mitotic timing, and accumulate more damage and at an exacerbated rate in 
comparison to control cells during a prolonged mitotic arrest.   
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Figure 4: pRB-Deficient Cells Treated with the DNA Damaging Agent Doxorubicin were Competent to 
Arrest prior to Mitotic Entry. A) Representative immunofluorescence imaging of control and pRB-deficient 
cells treated with 500nM of Doxorubicin. B) Mitotic index of siSCR and siRB control conditions. A minimum 
of 1000 cells were scored per replicate for populations of control and pRB-deficient cells treated with four 
different concentrations of Doxorubicin (250nM, 500nM, 750nM, and 2µM). All Doxorubicin treated 
populations exhibited complete arrest with no apparent mitotic figures. A total of 3 replicates were completed. 
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Figure 5: pRB-Deficient Cells Accumulate more γH2AX foci and do so at an Exacerbated Rate. 
Quantification of γH2AX foci scored after immunofluorescence imaging of RPE-1 cells. Cells were treated with 
either siSCR or siRB, and mitotic arrest was induced using the microtubule poison nocodazole for 4hr, 8hr, 
16hr, or 20hr. P-values were calculated by a two-tailed t-test across conditions. Bolded values indicate 
significance. Three replicates for all conditions, but additional fourth replicate for control, 8hr arrest, and 20hr 
arrest conditions.  
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Caspase Inhibition Partially Corrects Mitotic DNA Damage in pRB-Deficient Cells 
  
 At this point it has been proposed that pRB-deficient cells acquire DNA damage during prolonged 
mitoses and do so at an exacerbated rate in comparison to control cells. Previous literature has shown that in 
control cells, it is the partial activation of the caspase-dependent apoptotic pathway that causes DNA damage 
acquisition during prolonged mitoses (Orth et al., 2012). Inhibition of cleaved caspase activity was shown to 
restore DNA damage in cells undergoing a prolonged mitosis to control conditions (Orth et al., 2012), so I 
sought to determine if inhibition of caspase activity would also restore DNA damage in pRB-deficient cells 
undergoing a prolonged mitosis. Control and pRB-deficient cells were treated with nocodazole for 8 hours 
either in the presence or absence of the caspase inhibitor Z-VAD-FMK, and γH2AX foci accumulation was 
scored from immunofluorescence imaging to determine levels of DNA damage. The data shows that DNA 
damage in both control and pRB-deficient cells undergoing prolonged mitoses is partially corrected when 
caspase activity is inhibited (Figure 6). Thus, pRB-deficient cells are sensitive to caspase-dependent DNA 
damage during prolonged mitoses similar to control cells.  
 
Enhancing Chromatid Cohesion does not correct Mitotic DNA Damage 
 
 Enhancing sister chromatid cohesion by inhibiting the negative regulator of cohesion Wapl has been 
shown to correct DNA damage in pRB-deficient interphase cells, and thus damage induced by replication stress 
(Manning et al., 2010). In order to determine if improper cohesion is also mechanistically responsible for 
regulating mitotic DNA damage in control and pRB-deficient cells, codepletion of pRB and Wapl using RNA 
interference was completed (Figure 7A), and γH2AX foci accumulation was scored from immunofluorescence 
imaging to determine levels of DNA damage. The data shows that mitotic DNA damage in both control and 
RB-deficient cells is not suppressed by depletion of Wapl (Figure 7B). This suggests that despite the accepted 
theory that pRB loss is associated with cohesion defects and chromosomal instability, mitotic DNA damage is 
not mechanistically regulated by chromatid cohesion.    
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Figure 6: Caspase Inhibition Partially Corrects DNA Damage acquired during Prolonged Mitosis. 
Quantification of γH2AX foci scored after immunofluorescence imaging of RPE-1 cells. Cells were treated with 
siSCR or siRB and mitotic arrest was induced using the microtubule poison nocodazole for 8hr or 20hr. Caspase 
inhibition was accomplished using the inhibitor Z-VAD-FMK. P-values were calculated by a two-tailed t-test 
across conditions. Bolded values indicate significance. A total of 7 replicates were completed.  
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Figure 7: Enhancing Cohesion via Depletion of Negative Regulator WAPL has no effect on Mitotic DNA 
Damage. Quantification of γH2AX foci scored after immunofluorescence imaging of RPE-1 cells. Cells were 
treated with siSCR, siRB, and/or siWAPL and mitotic arrest was induced using the microtubule poison 
nocodazole for 8hr or 20hr. P-values were calculated by a two-tailed t-test across conditions. Bolded values 
indicate significance. All conditions were performed a minimum of 3 replicates, with all siRB conditions 
completed with 3 additional replicates.   
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γH2AX Accumulation during 8 Hour Mitotic Arrest is Conserved in Cancer Cell Line 
 
 All data thus far has suggested that when RPE-1 cells are depleted of pRB and undergo a prolonged 
mitosis, they accumulate more DNA damage dependent γH2AX foci than control mitotics and do so at an 
exacerbated rate in comparison to control cells also undergoing a prolonged mitosis. The immunofluorescence 
data is complemented by western blot in HCT-116 cells (Figure 8A,B), confirming that an 8-hour mitotic arrest 
induced by the microtubule poison nocodazole accelerates DNA double stranded break acquisition in pRB-
deficient cells. This data suggests that γH2AX accumulation in pRB-deficient cells undergoing prolonged 
mitoses is conserved in HCT116 cells, further promoting an opportunistic therapeutic phenotype for pRB-
deficient cancers.  
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Figure 8: γH2AX DNA Damage Foci Accumulation in RB-Deficient Cells Conserved in HCT116 Cell 
Line. A) Western blot of Rb, γH2AX, and tubulin for asynchronous HCT116 cells or those treated with 
nocodazole for the indicated time points. B) Quantification of panel A (3 replicates). The data in this figure was 
generated by Ripudaman Singh.
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
Control +Doxy Control +NOC +Doxy +NOC 
Fo
ld
 C
ha
ng
e 
in
 E
xp
re
ss
io
n 
RB 
yH2AX 
p53 
   -Doxy                  +Doxy              -Doxy           +Doxy 
              +NOC           +NOC 
 
RB 
 
P53 
 
Tubulin 
 
γH2AX 
 
Tubulin 
#3                          Control                         Doxy                              Noc                            Doxy + Noc  
Tubulin (Set 3) 
Rb 
 
               100                                             4.2                                       77.5                                        6.8 
P53 
 
               100                                             115                                      226.3                                        310.2 
Tubulin 
 
yH2AX 
 
               100                                             623                                      856.4                                        1765.3 
#3                          Control                         Doxy                              Noc                            Doxy + Noc  
Tubulin (Set 3) 
Rb 
 
               100                                             4.2                                       77.5                                        6.8 
P53 
 
               100                                             115                                      226.3                                        310.2 
Tubulin 
 
yH2AX 
 
               100                                             623                                      856.4                                        1765.3 
#3                          Control                         Doxy                              Noc                            Doxy + Noc  
Tubulin (Set 3) 
Rb 
 
               100                                             4.2                                       77.5                                        6.8 
P53 
 
               100                                             115                                      226.3                                        310.2 
Tubulin 
 
yH2AX 
 
               100                                             623                                      856.4                                        1765.3 
#3                          Control                         Doxy                              Noc                            Doxy + Noc  
Tubulin (Set 3) 
Rb 
 
               100                                             4.2                                       77.5                                        6.8 
P53 
 
               100                                             115                                      226.3                                        310.2 
Tubulin 
yH2AX 
 
               100                                             623                                      856.4                                        1765.3 
#3                          Control                         Doxy                              Noc                            Doxy + Noc  
Tubulin (Set 3) 
Rb 
 
               100                                             4.2                                       77.5                                        6.8 
P53 
 
               100                                             115                                      226.3                                        310.2 
Tubulin 
 
yH2AX 
 
               100                                             623                                      856.4                                        1765.3 
 19 
Chapter III: Conclusions and Future Directions 
 
pRB-Deficient Cells Acquire More DNA Damage than Control Cells during Normal Mitotic Timing and 
Abnormal Mitoses and do so at an Exacerbated Rate 
 
 Results have shown that pRB-deficient cells acquire more mitotic DNA damage than control cells, and 
that the level of DNA damage is exacerbated in response to the microtubule poison nocodazole. It has 
previously been recognized that control cells have increased levels of DNA damage during prolonged mitotic 
events (Orth et al., 2012), but the data considering the role of key cell cycle regulator pRB in regulating mitotic 
DNA damage is novel. Throughout a time course of induced mitotic arrest, it was demonstrated pRB-deficient 
arrested cells begin to acquire DNA damage as early as 4 hours, while control arrested cells do not begin to 
show significant changes in levels of DNA damage until 8 hours. In addition, despite DNA damage being 
present in both control and pRB-deficient cells during the 8 hours mitotic arrest time point, pRB-deficient cells 
acquire higher levels of DNA damage in comparison to their counterpart. Due to the evidence that pRB-
deficient cells acquire mitotic DNA damage at higher rates than control cells, pRB-deficient cells have a novel 
mitotic regulatory role to be appreciated.    
 Mechanistically, the working model proposed for pRB-regulated acquisition of mitotic DNA damage 
originally theorized three different processes (Figure 9). First, it was hypothesized that loss of pRB accelerates 
the decrease in expression levels of anti-apoptotic factors to reach the threshold that activates caspase and 
DNase activity. The data in Figure 6 suggests that similar to the literature, caspase inhibition lowers the levels 
of DNA damage in control cells undergoing abnormal mitoses. This phenotype holds true in pRB-deficient 
cells, but there is also a smaller population of cells with damage in general when caspase activity is inhibited. 
This suggests a prominent role for pRB associated caspase activation, and requires further analysis of the levels 
of anti-apoptotic factors in pRB-deficient cells to more accurately describe the mechanism of DNA damage 
acquisition. Also required is a quantified protein analysis of cleaved caspase in control and pRB-deficient cells 
undergoing prolonged mitotic events.    
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Figure 9: A Model of pRB-Regulated Acquisition of Mitotic DNA Damage 
 
 Alongside this and due to the regulatory function of pRB in maintaining accurate chromosome cohesion 
and condensation, it was also hypothesized that loss of pRB disrupts cohesion and/or condensation and thus 
leaves regions of the chromosome exposed for DNA damage (Figure 9).  The data in Figure 7, which analyzed 
whether increasing chromatid cohesion would limit the acquisition of DNA damage in pRB-deficient cells 
undergoing prolonged mitoses, shows that the accepted role of pRB in regulating cohesion has no influence on 
mitotic DNA damage. In addition to these experiments, enhancing chromosome condensation should also be 
explored to determine if optimal function of pRB in condensation limits mitotic DNA damage.   
 
Future Directions and Clinical Relevance  
 
 The data outlined above reveals a role for pRB in the regulation of mitotic DNA damage. 
Mechanistically, there are several options that still need to be experimentally optimized and investigated. First, 
the data above suggested that the G2/M DNA damage checkpoint in pRB-deficient cells remains intact due to 
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the inability to observe mitotic figures when such cells are treated with doxorubicin at doses ranges from 
250nM to 2µM. This experiment could be verified with live cell microscopy, in which G2 pRB-deficient cells 
with DNA damage can be monitored on if they enter mitosis. Another important question to consider is was the 
range of doxorubicin appropriate, or more specifically what is the lowest concentration of doxorubicin that will 
still allow mitotic entry in both control and pRB-deficient cells. It is possible that this concentration would 
differ between control and pRB-deficient cells, suggesting that a higher amount of DNA damage in pRB-
deficient cells is able to bypass the checkpoint in comparison to control cells. This would further support the 
literature, which shows how the phosphorylation of RB is regulated in an ATM Chk1/2 dependent manner in 
response to DNA damage (Inoue et al., 2007). 
 Alongside further analysis of DNA damage acquisition is exploring whether pRB-deficient cells that 
escape the mitotic arrest either correct DNA damage or activate the apoptotic pathway during the subsequent 
G1 phase of the cell cycle. It is hypothesized that since pRB regulates the G1/S phase checkpoint, correction of 
DNA damage will be compromised in pRB-deficient cells during the next cell cycle. This experiment could be 
accomplished using FACS analysis, in which a population of G1 cells washed out from cells previously arrested 
in mitosis will be analyzed for activation of the DNA damage response pathway. Specifically, the expression 
levels of proteins involved in nonhomologous end joining will be monitored to conclude whether the DNA 
damage acquired in mitosis has induced the DNA damage response for correction before subsequent DNA 
duplication and whether this holds in pRB-deficient cells.  
 Another possibility in relation to activation of the DNA damage response pathway that should be 
considered is if the repair pathway is being activated in response to prolonged mitotic arrest in control and pRB-
deficient cells. It has been shown that activation of the DNA damage response pathway in mitosis induces 
chromosome segregation defects (Bakhoum et al., 2014). Similarly, pRB loss has been associated with 
chromosomal instability (Manning et al., 2010). Chromosomal instability may be an underlying cause or 
response to DNA damage, thus it is possible that pRB loss promotes DNA damage, which drives activation of 
the DNA damage response pathway, and subsequently promotes chromosomal instability.  
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 The data above supports that the mitotic DNA damage phenotype observed in pRB-deficient mitotic 
cells is significant and conserved in a cancer cell line. Clinically, this is relevant as several cancers are 
characterized by pRB loss of function. To target this phenotype in cancer, I began to explore whether pRB-
deficient cells are susceptible to mitotic arrest. To do this, control and pRB-deficient cells were treated with 
three different small molecules that induce mitotic arrest, and the viability of these cells was measured 3 days 
and 6 days after plating. There are several areas to improve on in this experiment, as the data collected showed 
variation due to the plate reader protocol set up as well as timing and concentration of small molecule inhibitor 
addition. If optimized for repeat experiments – in addition to chromosome condensation, caspase activation, and 
DNA damage response pathway analysis – the story behind pRB and mitotic DNA damage can be unraveled to 
provide therapeutic opportunities for pRB-deficient cancers.  
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Chapter IV: Methods 
 
Cell Culture  
 
 Human RPE-1 cells and RPE-1 cells expressing a pIND shRB were maintained in Dulbecco’s Modified 
Eagle Medium (DMEM), containing 10% Fetal Bovine Serum (FBS) and 50µg/mL streptomycin. Knockdown 
was accomplished in pIND RPE-1 cells by treating with 2µg/mL Doxycyclin hyclate (purchased from Sigma-
Aldrich, Cat #D8191) for 48 hours.  
shRB Sequence 
TGCTGTTGACAGTGAGCGCGCACTTCGATATCTACTGAAATACTGAAGCCACAGA
TGTATTTCAGTAGATATCGAACTGCTTGCCTACTGCCTCGGA 
Figure 10: Vector map and short hairpin sequence for pIND RPE-1 cells. Received from Steve Elledge lab. 
 
Antibodies 
 
 Antibodies used in this work included H2A.X (purchased from Cell Signaling, Cat. #2577L), Rb (4H1) 
(purchased from Cell Signaling, Cat. #9309L), and α-tubulin (DM1a) (purchased from Santa Cruz 
Biotechnology, Cat #sc-32293). All antibodies were used per the manufacturer’s recommendations.  
 
Small Molecules 
 
 Mitotic inhibitors used in this work included Nocodazole (purchased from Sigma-Aldrich, Cat #M1404, 
used at 100ng/mL), Monastrol (purchased from Sigma-Aldrich, Cat #M8515, used at 100µM), and Paclitaxel 
(purchased from Sigma-Aldrich, Cat #T7402, used at 10µM). DNA damaging agents used in this work included 
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Doxorubicin hydrochloride (purchased from Sigma-Aldrich, Cat #D1515, used at 250nM, 500nM, 750nM, and 
2µM) and Etoposide (purchased from Selleckchem, Cat #S1225, used at 2µg/mL and 1µg/mL. The caspase 
inhibitor used was Z-VAD-FMK (purchased from Bio Connect, Cat #sc-3607, used at 100µM). All molecules 
were dissolved in Dimethyl Sulfoxide (DMSO).  
 
siRNA Transfection 
 
 Approximately 60,000 RPE-1 cells were plated on coverslips in 12 well dishes the day of transfection 
and were grown without antibiotics. siRNA sequences in Table 2 were transfected into cells using 
Oligofectamine reagent through the following method: for one coverslip, the mixture of 3µL of desired siRNA 
incubated at room temperature for five minutes in 100µL of Opti-MEM reduced serum media per coverslip was 
combined with the mixture of 3µL of Oligofectamine reagent incubated at room temperature for five minutes in 
100µL of Opti-MEM reduced serum media. This was incubated at room temperature for 20 minutes. 
Immediately after adding the desired amount of cells, the 200µL transfection mixture was added to the cells. 
Cells treated with nocodazole for 16 or 20 hours proliferated for approximately 36 hours, upon which media 
containing antibiotics and the desired small molecule inhibitor was added. Cells treated with nocodazole for 4 
or 8 hours proliferated for approximately 48 hours, upon which media containing antibiotics and the desired 
small molecule inhibitor was added.  
 
Immunofluorescence Staining and Microscopy  
 
 RPE-1 cells on glass coverslips were fixed for 20 minutes at room temperature in pre-warmed 4% 
paraformalydhyde/phosphate-buffered saline (PBS), extracted with 1X PBS/0.5% Triton X100 for 10 minutes, 
and blocked in TBS/BSA for 20 minutes. In between each step, cells were washed with 1X PBS. Cells were 
then incubated for 90 minutes in primary antibody, washed 5 minutes in TBS/BSA, and incubated in the dark  
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Table 2: siRNA Sequences. Purchased from Thermo Scientific 
siRNA Catalog Number Target Sequence 
ON-TARGETplus Human 
RB1 
J-003296-23 GAACAGGAGUGCACGGAUA 
J-003296-24 GGUUCAACUACGCGUGUAA 
J-003296-25 CAUUAAUGGUUCACCUCGA 
J-003296-26 CAACCCAGCAGUUCGAUAU 
ON-TARGETplus Human 
WAPAL 
J-026287-09 GGAGUAUAGUGCUCGGAAU 
J-026287-10 GAGAGAUGUUUACGAGUUU 
J-026287-11 CAAACAGUGAAUCGAGUAA 
J-026287-12 CCAAAGAUACACGGGAUUA 
 
for 45 minutes with Alexa Fluor 488 anti-mouse IgG and 546 anti-rabbit IgG (purchased from Life 
Technologies, Cat #A-11029 and #A-11010 respectively). Cells were washed for 5 minutes in TBS/BSA, and 
the slips were mounted onto slides using ProLong Gold antifade mountant (purchased from Life Technologies, 
Cat #P36934). At least 50 cells per condition were imaged using a Nikon Ti-E inverted fluorescence 
microscope, using the 60X oil-immersion lens in Z-series. The details on the microscope are as follows. 
 Dr. Manning has a dedicated microscopy room, adjacent to her wet lab research space, equipped with a 
Nikon Ti-E inverted fluorescence microscope on an antivibration table.  The microscope is outfitted with Nikon 
objectives including: 10x CFI Plan Fluor for phase and immunofluorescence imaging; 20x and 40x CFI Plan 
Fluor extra long working distance objectives for immunofluorescence of multi well imaging plates; and a 60x 
Plan Apo oil immersion objective for high magnification imaging.  Filter sets for DAPI, EGFP, DSRed, and 
Cy5 enable 4-channel imaging and capture with a Zyla sCMOS camera. An XY-encoded stage and NIS 
Elements software permit fully automated, semi-high throughput imaging of both slides and multi well plates. 
An InVivo Environmental incubator chamber allows for temperature and CO2 control to enable multiday live 
cell imaging.  Two image analysis stations running NIS Elements and Cell Profiler software compliment the 
imaging set up. 
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Quantification of DNA Damage   
 
 To quantify the amount of DNA damage in mitotic cells, cells were categorized through manual 
counting into three ranges of H2A.X foci. Cells were considered to have no damage if no yH2AX foci were 
present, low damage if 1-4 yH2AX foci were present, or high damage if 5 or more yH2AX foci were present. 
 
Immunoblotting 
  
 For immunoblots, 10^7 cells/mL were collected per condition and were solubilized directly in 1X SDS-
PAGE sample buffer. Total cell protein was then separated by size using SDS-PAGE and transferred to either 
PVDF membrane (RB immunoblots) or nitrocellulose (H2A.X). For RB immunoblots, primary antibodies were 
incubated overnight at 4 degrees Celsius in 5% milk, 1X TBS, 0.1% Tween 20. For H2A.X immunoblots, 
primary antibodies were incubated overnight at 4 degrees Celsius in 5% BSA, 1X TBS, 0.1% Tween 20. 
Primary antibody was then detected using HRP-conjugated secondary antibodies diluted in 1X TBS, 0.1% 
Tween 20 for one hour at room temperature. The signal was then detected using film.  
 
Proliferation Assay 
 
 RPE-1 cells expressing pIND shRB were grown for 48 hours either in the absence or presence of 
Doxycyclin hyclate. 3000 cells/well were then plated on a 96 well dish in the presence of either no drug, 
nocodazole, monastrol, paclitaxel, doxorubicin, or etoposide. Doxycyclin hyclate was readded to desired cells 
upon plating. After three and six days, PrestoBlue Cell Viability Reagent (Invitrogen, Cat. #A13262) was added 
to cells and a viability reading was performed reading Alamar Blue at fluorescence 544 and emission 590.  
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